ZoomRx is a specialized life sciences consulting firm that provides strategic insights, market research, and advanced analytics to pharmaceutical, biotechnology, and medical device companies. The firm integrates proprietary data infrastructure with AI-enhanced analytics to support clients across the entire drug development lifecycle, from pre-launch strategy to post-launch commercial optimization. Founded in 2011, the company is headquartered in Cambridge, Massachusetts, with significant global operations in New York and Chennai, India. ZoomRx is known for its vertically integrated model that combines high-touch strategic consulting with proprietary technology platforms, such as Sagan (AI market research) and Ferma (intelligence and workflow automation), to help biopharma leaders make data-driven commercial decisions.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Life Sciences Consulting & Market Research
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:2011
Ownership:private
Status:operating
FUNDING
Total Raised:$0M
0
CORPORATE STRUCTURE
Key Partnerships:Works with 19 of the top 20 global biopharma companies.
COMPETITION
Position:Niche Player
Competitors:Indegene, IntegriChain, Zuellig Pharma
LEADERSHIP
Key Executives:
Sriram Subramanian - CEO and Co-Founder
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ZoomRx and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ZoomRx. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.